NYSE
Stocks shot up Tuesday, propelled by a strong U.S. retail sales report and German investor confidence survey and a statement by the Federal Open Market Committee noting improvement in household and business spending as well as job creation. REUTERS

The top after-market NYSE gainers Thursday were Accretive Health, Lloyds Banking Group Plc, Lloyds Banking Group Plc, Lloyds Banking Group Plc and Beazer Homes USA. The top after-market NYSE losers were Western Asset Premier Bond Fund, Equus Total Return, Eagle Materials, Proto Labs and Health Management Associates.

Gainers

Accretive Health Inc. (AH) shares surged 3.59 percent to $11.89 in post-market trading. The company stock slumped more than 11 percent in regular trading.

Lloyds Banking Group Plc (LYG) surged 3.17 percent to $2.60 in post-market trading. European banking stocks have rebounded sharply in the last month as euro recovered on hopes of central bank actions.

Och-Ziff Capital Management Group LLC (OZM) shares gained 3.06 percent to $9.44 in post-market trading. The stock has a 52-week low of $6.56, a 52-week high of $11.44 and $3.81 billion in market capitalization.

Manitowoc Co Inc. (MTW) shares advanced 2.57 percent to $15.18 in post-market trading.

Beazer Homes USA Inc. (BZH) shares gained 2.56 percent to $3.60 in post-market trading after climbing more than 7 percent in regular trading.

Losers

Western Asset Premier Bond Fund (WEA) shares tumbled 8.72 percent to $15.29 in post-market trading.

Equus Total Return Inc. (EQS) shares declined 2.94 percent to $2.22 in post-market trading.

Eagle Materials Inc. (EXP) shares fell 2.84 percent to $45.79 in post-market trading. The stock has a 52-week low of $15.36, a 52-week high of $47.36 and $2.14 billion in market capitalization.

Proto Labs Inc. (PRLB) share declined 2.59 percent to $31.94 in post-market trading. The stock has a 52-week low of $24.07, a 52-week high of $41.10 and $784.85 million in market capitalization.

Health Management Associates Inc. (HMA) shares declined 2.21 percent to $7.96 in post-market trading. The company stock gained nearly 3 percent in regular trading as healthcare stocks rallied following the announcement of QE3 by the Fed.

Nyse Management